Regulation of Lipid Metabolism in Guangzhou Individuals With Dyslipidemia by Red Yeast Rice, Phytosterol Esters and Lycopene - Trial NCT05836909
Access comprehensive clinical trial information for NCT05836909 through Pure Global AI's free database. This phase not specified trial is sponsored by Lili Yang and is currently Enrolling by invitation. The study focuses on Hypercholesterolemia. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Lili Yang
Sun Yat-sen University
Timeline & Enrollment
N/A
May 01, 2023
Apr 30, 2024
Primary Outcome
Change in levels of total cholesterol
Summary
The objective of this study is to evaluate the effect of using red yeast rice, phytosterol
 esters and lycopene in combination for 12 weeks on improving the glycolipid metabolism of
 Guangzhou individuals with dyslipidemia. Our hypothesis is that when compared with placebo,
 red yeast rice, phytosterol esters and lycopene together as supplements would lead to greater
 improvements in lipid metabolism (including lipid profiles and parameters ) in participants
 after 12 weeks.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05836909
Non-Device Trial